ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer$1. .$1
Biotechnology β’ technology β’ artificial intelligence β’ cancer β’ immunology
201 - 500
π₯ Funding within the last year
π° Series C on 2024-09
October 25
201 - 500
Spearhead regulatory affairs for CAR T-cell therapies at ArsenalBio.
πΊπΈ United States β Remote
π΅ $285.7k - $350k / year
π₯ Funding within the last year
π° Series C on 2024-09
β° Full Time
π΄ Lead
π Compliance